These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Polyol pathway activity in nervous tissues of diabetic and galactose-fed rats: effect of dietary galactose withdrawal or tolrestat intervention therapy. Sredy J; Sawicki DR; Notvest RR J Diabet Complications; 1991; 5(1):42-7. PubMed ID: 1830318 [TBL] [Abstract][Full Text] [Related]
6. Administration of ascorbic acid and an aldose reductase inhibitor (tolrestat) in diabetes: effect on urinary albumin excretion. McAuliffe AV; Brooks BA; Fisher EJ; Molyneaux LM; Yue DK Nephron; 1998 Nov; 80(3):277-84. PubMed ID: 9807036 [TBL] [Abstract][Full Text] [Related]
7. Prevention of urinary albumin excretion in 6 month streptozocin-diabetic rats with the aldose reductase inhibitor tolrestat. McCaleb ML; Sredy J; Millen J; Ackerman DM; Dvornik D J Diabet Complications; 1988; 2(1):16-8. PubMed ID: 2968349 [TBL] [Abstract][Full Text] [Related]
8. Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats. Cotter MA; Cameron NE; Hohman TC J Peripher Nerv Syst; 1998; 3(3):217-23. PubMed ID: 10959252 [TBL] [Abstract][Full Text] [Related]
9. Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy. Finegold D; Lattimer SA; Nolle S; Bernstein M; Greene DA Diabetes; 1983 Nov; 32(11):988-92. PubMed ID: 6416910 [TBL] [Abstract][Full Text] [Related]
10. Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil. Beyer-Mears A; Ku L; Cohen MP Diabetes; 1984 Jun; 33(6):604-7. PubMed ID: 6427041 [TBL] [Abstract][Full Text] [Related]
11. Effects of polyol-pathway inhibition and dietary myo-inositol on glomerular hemodynamic function in experimental diabetes mellitus in rats. Goldfarb S; Ziyadeh FN; Kern EF; Simmons DA Diabetes; 1991 Apr; 40(4):465-71. PubMed ID: 2010046 [TBL] [Abstract][Full Text] [Related]
12. Prevention of neural myoinositol depletion in diabetic rats by aldose reductase inhibition with tolrestat. Kemper C; Dvornik D Proc Soc Exp Biol Med; 1986 Sep; 182(4):505-10. PubMed ID: 3090558 [TBL] [Abstract][Full Text] [Related]
13. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats. Schmidt RE; Plurad SB; Sherman WR; Williamson JR; Tilton RG Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats. Cameron NE; Cotter MA; Basso M; Hohman TC Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964 [TBL] [Abstract][Full Text] [Related]
15. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil. Whiting PH; Ross IS Br J Exp Pathol; 1988 Oct; 69(5):697-702. PubMed ID: 3143396 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of Zopolrestat and Sorbinil on lens myo-inositol influx. Beyer-Mears A; Diecke FP; Mistry K; Cruz E Pharmacology; 1997 Feb; 54(2):76-83. PubMed ID: 9088040 [TBL] [Abstract][Full Text] [Related]
17. Does galactose feeding provide a valid model of consequences of exaggerated polyol-pathway flux in peripheral nerve in experimental diabetes? Willars GB; Lambourne JE; Tomlinson DR Diabetes; 1987 Dec; 36(12):1425-31. PubMed ID: 3678622 [TBL] [Abstract][Full Text] [Related]
18. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy. Shindo H; Tawata M; Aida K; Onaya T J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506 [TBL] [Abstract][Full Text] [Related]
19. Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors. Tilton RG; Chang K; Pugliese G; Eades DM; Province MA; Sherman WR; Kilo C; Williamson JR Diabetes; 1989 Oct; 38(10):1258-70. PubMed ID: 2507378 [TBL] [Abstract][Full Text] [Related]
20. Effect of vanadate administration on polyol pathway in diabetic rat kidney. Saxena AK; Srivastava P; Kale RK; Baquer NZ Biochem Int; 1992 Feb; 26(1):59-68. PubMed ID: 1616498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]